Celcuity (CELC) Retained Earnings (2016 - 2025)
Celcuity (CELC) posted Retained Earnings of -$448.9 million for Q4 2025, down 12.81% on a QoQ basis from -$397.9 million in Q3 2025, and down 65.12% year-over-year from -$1.3 billion in Q4 2024.
Celcuity (CELC) Retained Earnings (2016 - 2025) Analysis & Trends
Celcuity's Retained Earnings history runs 10 years deep, the most recent figure standing at -$448.9 million for Q4 2025.
- Quarterly Retained Earnings fell 65.12% year-over-year to -$448.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$448.9 million (down 65.12% YoY) and the FY2025 annual result came in at -$448.9 million, down 65.12% from the prior year.
- Retained Earnings was -$448.9 million for Q4 2025 at Celcuity, down from -$397.9 million in the prior quarter.
- Across five years, Retained Earnings topped out at $398.5 million in Q2 2025 and bottomed at -$448.9 million in Q4 2025.
- A 5-year average of -$57.6 million and a median of -$79.3 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2021 — Retained Earnings slumped 231.05% — and 2022, when it surged 511.33%.
- Celcuity's Retained Earnings stood at -$55.9 million in 2021, then jumped by 511.33% to $230.0 million in 2022, then slumped by 169.58% to -$160.1 million in 2023, then plunged by 69.83% to -$271.9 million in 2024, then sank by 65.12% to -$448.9 million in 2025.
- Business Quant data shows CELC's Retained Earnings at -$448.9 million in Q4 2025, -$397.9 million in Q3 2025, and $398.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Celcuity | 4.13 Bn | 4.13 Bn | - | -448.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -448.90 Mn |
| Sep 30, 2025 | -397.92 Mn |
| Jun 30, 2025 | 398.46 Mn |
| Mar 31, 2025 | -308.85 Mn |
| Dec 31, 2024 | -271.86 Mn |
| Sep 30, 2024 | 384.87 Mn |
| Jun 30, 2024 | -205.41 Mn |
| Mar 31, 2024 | -181.69 Mn |
| Dec 31, 2023 | -160.08 Mn |
| Sep 30, 2023 | 234.10 Mn |
| Jun 30, 2023 | -122.82 Mn |
| Mar 31, 2023 | -108.24 Mn |
| Dec 31, 2022 | 230.05 Mn |
| Sep 30, 2022 | -84.72 Mn |
| Jun 30, 2022 | -73.82 Mn |
| Mar 31, 2022 | -63.86 Mn |
| Dec 31, 2021 | -55.93 Mn |
| Sep 30, 2021 | -49.17 Mn |
| Jun 30, 2021 | 70.17 Mn |
| Mar 31, 2021 | 64.28 Mn |